DOAC stewardship is an essential need. In a recent paper, the CDC estimated between 2016-2020 there were 1.2 million emergency room visits due to oral anticoagulant-related bleeding. To mitigate risks associated with DOACs, different management models have been constructed and established across institutions and clinics worldwide. Join experts as they discuss a patient-focused DOAC model similar to warfarin management at Brigham & Women’s Hospital as well as a population health model used across VHA. A question-and-answer panel will address the value of DOAC oversight by anticoagulation services.

Speakers:
Katelyn Sylvester, PharmD, BCPS, CACP
Arthur Allen, PharmD, CACP
CDR Andrew Geller, MD
Jean Connors, MD
Andrea Van Beek, RN, DNP, AGPCNP-BC

The Anticoagulation Forum, in partnership with the National Quality Forum (NQF), and with funding from the U.S. Food and Drug Administration (FDA), is pleased to announce the release of "Advancing Anticoagulation Stewardship: A Playbook", a new, publicly available guide to help healthcare organizations implement evidence-based strategies to promote patient safety in the use of anticoagulant medications. This Playbook centers on the Anticoagulation Forum’s Core Elements of Anticoagulation Stewardship and offers concrete strategies and implementation examples for healthcare organizations and clinicians who wish to create, promote, and sustain an Anticoagulation Stewardship program.

Join key authors and contributors as they discuss the Playbook creation process and how best to use this new tool to advance stewardship at your practice.

Speakers:
Arthur Allen, PharmD, CACP
Allison Burnett, PharmD, PhC, CACP
Scott Kaatz, DO, MSc, FACP, SFHM
Chelsea Lynch, MPH, MSN, RN, CIC
Scott K. Winiecki, MD

In this webinar, Dr. Burnett defines anticoagulation stewardship and describes practice-level initiatives and national-level momentum behind these types of programs. She also discusses the role of pharmacists within the multidisciplinary team to promote anticoagulation stewardship for VTE patients throughout the continuum of care. Finally, she summarizes relevant clinical resources to aid clinicians in optimizing the care of VTE patients.

Part of the CDC’s Public Health Webinar Series on Blood Disorders.

Speakers:
Allison E. Burnett, PharmD, PhC, CACP
Caroline Cromwell, MD

Join us for a discussion about successful Anticoagulation Stewardship Program implementation. Dr. Daniel Budnitz from the CDC will describe his work quantifying AC-related harms over the years and where he sees the future going as a public health priority, touching upon his publication “US Emergency Department Visits Attributed to Medication Harms, 2017-2019”.

Stewardship teams from both Johns Hopkins Hospital and the University of Alabama at Birmingham will follow Dr. Budnitz and share their experiences implementing AC stewardship programs at their institutions. A panel will continue the conversation, opening questions to participants.

Speakers:
Dan Budnitz, MD, MPH, CAPT, USPHS
Kathryn Dane, PharmD
Scott Kaatz, DO, MSc, FACP, SFHM
Jori May, MD
Anne Rose, PharmD
Michael Streiff, MD
Andrea Van Beek, RN, DNP, AGPCNP-BC

Explores how the Core Elements of Anticoagulation Stewardship guide and other AC Forum resources can be leveraged to advance anticoagulation stewardship principles in a variety of patient care settings.

Speakers:
Allison E. Burnett, PharmD, PhC, CACP
Scott Kaatz, DO, MSc, FACP, SFHM
Tracy Minichiello, MD
Darren Triller, PharmD

Oral Anticoagulation Surveillance and Improvement Through Stewardship (OASIS) Program
2022-2024

The MIDAS Program is a 24-month project, funded by the FDA, though which the Anticoagulation Forum will assess hospital needs specific to DOAC prescribing surveillance processes and interventions.

By the end of 2024, this information will be used to develop, implement, and evaluate an EHR-based DOAC Dashboard that will be made publicly available through EPIC Turbocharger.

Mentored Implementation and Dissemination of Anticoagulation Stewardship (MIDAS) Program
2020-2022

The MIDAS Program was a 24-month project, funded by the FDA, through which five hospital sites were paired with nationally recognized anticoagulation experts. These mentors worked directly with care teams to use the Core Elements of Anticoagulation Stewardship to assess their stewardship baseline, identify interventional targets, develop an implementation strategy, and track program progress.

Information obtained from this process was used to develop “Advancing Anticoagulation Stewardship: A Playbook,” which provides guidance and resources to hospitals that wish to independently establish a stewardship program.